Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ge, R.-L.
Right arrow Articles by Kobayashi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ge, R.-L.
Right arrow Articles by Kobayashi, T.
(Chest. 1997;111:58-64.)
© 1997 American College of Chest Physicians

Low Pulmonary Diffusing Capacity in Subjects With Acute Mountain Sickness

Ri-Li Ge MD1; Yukinori Matsuzawa MD1; Michiko Takeoka PhD1; Keishi Kubo MD1; Morie Sekiguchi MD1; and Toshio Kobayashi MD1

1 From the First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan

This study was conducted to investigate whether the changes in the pulmonary diffusing capacity found in individuals with acute mountain sickness (AMS) reflect the early stage of high-altitude pulmonary edema (HAPE). We measured the pulmonary diffusion capacity for carbon monoxide (DCO) by the single-breath method, arterialized capillary blood gas, and spirometry in a group of 32 healthy subjects (24 men, eight women) at an altitude of 2,260 m and after ascent to 4,700 m. Twelve subjects (10 men, two women) had symptoms of AMS (AMS group) by the second day after arrival at 4,700 m, but none had clinical signs of pulmonary or cerebral edema. In the non-AMS group, almost all subjects exhibited an increase in DCO at 2,260 to 4,700 m (DgrDCO, 10.7±1.25 mL/min/mm Hg), while the degree of increase in DCO in the AMS group (n=12) was significantly lower (DgrDCO, 1.26±1.74 mL/min/mm Hg) than that of the non-AMS group (p<0.01). In four of the 12 subjects with AMS who had a high AMS score, DCO decreased from 38.4±4.5 to 33.2±5.3 mL/min/mm Hg (DgrDCO, minus5.84±1.1 mL/min/mm Hg). The AMS group showed significantly lower vital capacity, forced expiratory flow during the middle half of FVC, Pa02, and a greater alveolar-arterial oxygen pressure difference at 4,700 m compared with the non-AMS group. DCO showed a significant negative correlation with AMS score (r=minus0.885) and a positive correlation with PaO2 (r=0.757) at 4,700 m. These results suggest that the decreased pulmonary diffusing capacity in subjects with AMS reflects the presence of pulmonary gas exchange abnormality, which is probably due to subclinical interstitial edema of the lung.

Key Words: acute mountain sickness • blood gas • diffusion capacity • high altitude • lung volume • subclinical edema

Submitted on December 7, 1995
Accepted on July 30, 1996




This article has been cited by other articles:


Home page
J. Exp. Biol.Home page
R. C. Roach and P. H. Hackett
Frontiers of hypoxia research: acute mountain sickness
J. Exp. Biol., March 11, 2002; 204(18): 3161 - 3170.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
T. C. Carpenter, J. T. Reeves, and A. G. Durmowicz
Viral respiratory infection increases susceptibility of young rats to hypoxia-induced pulmonary edema
J Appl Physiol, March 1, 1998; 84(3): 1048 - 1054.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American College of Chest Physicians.